These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19683892)

  • 1. Overuse of stress ulcer prophylaxis in the critical care setting and beyond.
    Farrell CP; Mercogliano G; Kuntz CL
    J Crit Care; 2010 Jun; 25(2):214-20. PubMed ID: 19683892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication reconciliation effect on prolonged inpatient stress ulcer prophylaxis.
    Zeigler AJ; McAllen KJ; Slot MG; Barletta JF
    Ann Pharmacother; 2008 Jul; 42(7):940-6. PubMed ID: 18577762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients.
    Heidelbaugh JJ; Inadomi JM
    Am J Gastroenterol; 2006 Oct; 101(10):2200-5. PubMed ID: 16952283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate continuation of stress ulcer prophylaxis beyond the intensive care setting.
    Farley KJ; Barned KL; Crozier TM
    Crit Care Resusc; 2013 Jun; 15(2):147-51. PubMed ID: 23961576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit.
    Murphy CE; Stevens AM; Ferrentino N; Crookes BA; Hebert JC; Freiburg CB; Rebuck JA
    Pharmacotherapy; 2008 Aug; 28(8):968-76. PubMed ID: 18657013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate continuation of stress ulcer prophylactic therapy after discharge.
    Wohlt PD; Hansen LA; Fish JT
    Ann Pharmacother; 2007 Oct; 41(10):1611-6. PubMed ID: 17848420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress ulcer prophylaxis: reducing non-indicated prescribing after hospital discharge.
    Hatch JB; Schulz L; Fish JT
    Ann Pharmacother; 2010 Oct; 44(10):1565-71. PubMed ID: 20841521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries.
    Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; McArthur C; Cook D; Nielsen N; Pelosi P; Keus F; Guttormsen AB; Moller AD; Møller MH;
    Acta Anaesthesiol Scand; 2015 May; 59(5):576-85. PubMed ID: 25880349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress ulcer prophylaxis for non-critically ill patients on a teaching service.
    Hwang KO; Kolarov S; Cheng L; Griffith RA
    J Eval Clin Pract; 2007 Oct; 13(5):716-21. PubMed ID: 17824863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of use of prophylaxis for stress-related mucosal disease in patients admitted to the intensive care unit.
    Frandah W; Colmer-Hamood J; Nugent K; Raj R
    J Intensive Care Med; 2014; 29(2):96-103. PubMed ID: 22786980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of intensive care unit discharge time on patient outcome.
    Priestap FA; Martin CM
    Crit Care Med; 2006 Dec; 34(12):2946-51. PubMed ID: 17075364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress ulcer prophylaxis in hospitalized patients not in intensive care units.
    Grube RR; May DB
    Am J Health Syst Pharm; 2007 Jul; 64(13):1396-400. PubMed ID: 17592004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-related mucosal disease in the intensive care unit: an update on prophylaxis.
    Sesler JM
    AACN Adv Crit Care; 2007; 18(2):119-26; quiz 127-8. PubMed ID: 17473539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional burden of intensive care to rehospitalizations following kidney transplantation: a study of rate, causes, and risk factors.
    Lak M; Jalali AR; Badrkhahan SF; Hashemi M; Azizabadi Farahani M; Kardavani B; Ghaheri H; Naghizadeh MM
    Iran J Kidney Dis; 2008 Oct; 2(4):212-7. PubMed ID: 19377240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of stress ulcer prophylaxis algorithm study.
    Coursol CJ; Sanzari SE
    Ann Pharmacother; 2005 May; 39(5):810-6. PubMed ID: 15811900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and prognostic predictors of unexpected intensive care unit admission within 3 days after ED discharge.
    Fan JS; Kao WF; Yen DH; Wang LM; Huang CI; Lee CH
    Am J Emerg Med; 2007 Nov; 25(9):1009-14. PubMed ID: 18022494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidisciplinary drug-use evaluation for stress ulcer prophylaxis.
    Hatton J
    Am J Hosp Pharm; 1992 Jun; 49(6):1440-4. PubMed ID: 1529986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.
    Tasaka CL; Burg C; VanOsdol SJ; Bekeart L; Anglemyer A; Tsourounis C; Rennke S
    Ann Pharmacother; 2014 Apr; 48(4):462-9. PubMed ID: 24473490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The incidence of stress ulcers and the effectiveness of preventive alkalization treatment in patients scheduled for major vascular surgery. Prospective study].
    Bonazzi M; Lensi C; Migliavacca S; Bianchi de Grazia L; Cipolla M; Martino R; Riva A; Laveneziana D
    Minerva Anestesiol; 1998 Mar; 64(3):59-65. PubMed ID: 9677789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When should stress ulcer prophylaxis be used in the ICU?
    Quenot JP; Thiery N; Barbar S
    Curr Opin Crit Care; 2009 Apr; 15(2):139-43. PubMed ID: 19578324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.